Cai Lay Veterinary Pharmaceutical JSC (HNX:MKV)
9,000.00
-1,000.00 (-10.00%)
At close: Apr 4, 2025
HNX:MKV Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2019 | FY 2018 | 2016 - 2017 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2016 - 2017 |
Net Income | 7,324 | 6,201 | 5,904 | 1,767 | -217.54 | Upgrade
|
Depreciation & Amortization | 4,231 | 7,171 | 7,816 | 8,546 | 8,220 | Upgrade
|
Loss (Gain) From Sale of Assets | - | -467.33 | -196.35 | 17,853 | -35.79 | Upgrade
|
Other Operating Activities | -1,987 | 145.11 | -213.68 | -7,875 | 462.94 | Upgrade
|
Change in Accounts Receivable | -5,557 | -8,042 | -3,844 | 10,585 | 193.18 | Upgrade
|
Change in Inventory | -3,652 | 15,683 | 450.63 | 3,945 | 1,641 | Upgrade
|
Change in Accounts Payable | 4,842 | 4,650 | -2,471 | -13,298 | -288.78 | Upgrade
|
Change in Other Net Operating Assets | 395.47 | 49.34 | 145.92 | 384.62 | 434.13 | Upgrade
|
Operating Cash Flow | 5,597 | 25,391 | 7,592 | 21,909 | 10,410 | Upgrade
|
Operating Cash Flow Growth | -77.96% | 234.43% | -65.35% | 110.46% | - | Upgrade
|
Capital Expenditures | - | -984.46 | -561.05 | - | -2,945 | Upgrade
|
Sale of Property, Plant & Equipment | - | 181.82 | - | - | 27.5 | Upgrade
|
Other Investing Activities | 386.42 | 330.98 | 178.8 | 1.04 | 10.79 | Upgrade
|
Investing Cash Flow | 386.42 | -471.66 | -382.25 | 1.04 | -2,907 | Upgrade
|
Short-Term Debt Issued | 5,010 | 9,087 | 50,133 | - | - | Upgrade
|
Long-Term Debt Issued | - | - | - | 64,019 | 54,001 | Upgrade
|
Total Debt Issued | 5,010 | 9,087 | 50,133 | 64,019 | 54,001 | Upgrade
|
Short-Term Debt Repaid | -5,010 | -27,492 | -56,235 | - | - | Upgrade
|
Long-Term Debt Repaid | - | - | - | -85,126 | -72,611 | Upgrade
|
Total Debt Repaid | -5,010 | -27,492 | -56,235 | -85,126 | -72,611 | Upgrade
|
Net Debt Issued (Repaid) | - | -18,405 | -6,102 | -21,107 | -18,611 | Upgrade
|
Common Dividends Paid | - | -1,500 | - | - | - | Upgrade
|
Financing Cash Flow | - | -19,905 | -6,102 | -21,107 | -18,611 | Upgrade
|
Net Cash Flow | 5,983 | 5,014 | 1,108 | 802.87 | -11,107 | Upgrade
|
Free Cash Flow | 5,597 | 24,406 | 7,031 | 21,909 | 7,465 | Upgrade
|
Free Cash Flow Growth | -77.07% | 247.11% | -67.91% | 193.49% | - | Upgrade
|
Free Cash Flow Margin | 5.23% | 22.01% | 5.88% | 21.39% | 5.55% | Upgrade
|
Free Cash Flow Per Share | 1119.37 | 4881.24 | 1406.48 | - | - | Upgrade
|
Cash Interest Paid | 38.53 | 577.22 | 1,157 | 3,830 | 4,920 | Upgrade
|
Cash Income Tax Paid | 3,431 | 1,300 | 1,475 | 1,040 | 72.67 | Upgrade
|
Levered Free Cash Flow | 6,521 | 26,537 | - | 14,676 | - | Upgrade
|
Unlevered Free Cash Flow | 6,546 | 26,838 | - | 17,108 | - | Upgrade
|
Change in Net Working Capital | 5,222 | -13,969 | - | -3,490 | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.